These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 16703056)

  • 1. Drug management.
    Baker R
    Br Dent J; 2006 May; 200(9):473-4. PubMed ID: 16703056
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
    [No Abstract]   [Full Text] [Related]  

  • 3. Disambiguating the bisphosphonates.
    Van den Wyngaert T; Huizing MT; Vermorken JB
    Ann Oncol; 2008 Jul; 19(7):1357-1359. PubMed ID: 18522931
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonate actions: physical chemistry revisited.
    Papapoulos SE
    Bone; 2006 May; 38(5):613-6. PubMed ID: 16504613
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonates and avascular necrosis of alveolar bone: a potential threat to dental implants.
    Garg AK
    Dent Implantol Update; 2006 Oct; 17(10):73-8. PubMed ID: 17066981
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological treatment of osteonecrosis.
    Aspenberg P
    Acta Orthop; 2006 Apr; 77(2):175-6. PubMed ID: 16752277
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonates and glucocorticoids: effects on bone quality.
    Lems WF
    Arthritis Rheum; 2007 Nov; 56(11):3518-22. PubMed ID: 17968935
    [No Abstract]   [Full Text] [Related]  

  • 8. Slumbering time-bomb.
    Dean F
    Br Dent J; 2006 Sep; 201(5):249. PubMed ID: 16960582
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of bone metastases with bisphosphonates].
    Gremaud M; Delouche D; Monnerat C
    Rev Med Suisse; 2006 Aug; 2(75):1861-6. PubMed ID: 16948423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warning: bisphosphonates and osteochemonecrosis of the jaws.
    Flint SR; Sharkey S; Galvin S
    J Ir Dent Assoc; 2006; 52(2):79-83. PubMed ID: 16989369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in men.
    Joy M
    N Engl J Med; 2008 Aug; 359(8):868; author reply 869. PubMed ID: 18724403
    [No Abstract]   [Full Text] [Related]  

  • 12. Biennial [corrected] IV zoledronic acid (Reclast) for prevention of osteoporosis.
    Med Lett Drugs Ther; 2009 Jun; 51(1315):49. PubMed ID: 19556940
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of zoledronic acid on bone pain secondary to metastatic bone disease.
    Rotjanapan P
    Med Health R I; 2009 Jan; 92(1):27-9. PubMed ID: 19248423
    [No Abstract]   [Full Text] [Related]  

  • 14. [Osteoporosis--new therapeutic possibilities. The Danish Bone Society].
    Langdahl BL; Rejnmark L;
    Ugeskr Laeger; 2008 Mar; 170(12):1043. PubMed ID: 18397661
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonates and bone turnover in premenopausal women receiving adjuvant chemotherapy.
    Paterson A; Baker T
    J Clin Oncol; 2009 Mar; 27(7):1005-6. PubMed ID: 19171701
    [No Abstract]   [Full Text] [Related]  

  • 16. Bisphosphonates as adjuvant therapy.
    Shapiro CL
    Clin Adv Hematol Oncol; 2009 May; 7(5):319-20. PubMed ID: 19521319
    [No Abstract]   [Full Text] [Related]  

  • 17. Bisphosphonate: a novel treatment for pigmented villonodular synovitis.
    Namazi H
    Ann Surg Oncol; 2008 Aug; 15(8):2350-1. PubMed ID: 18214618
    [No Abstract]   [Full Text] [Related]  

  • 18. CALGB 90202.
    Clin Adv Hematol Oncol; 2006 Dec; 4(12):897-8. PubMed ID: 17235272
    [No Abstract]   [Full Text] [Related]  

  • 19. Dental management of patients with a history of bisphosphonate therapy: clinical dilemma.
    Migliorati CA; Hsu CJ; Chopra S; Kaltman SS
    J Calif Dent Assoc; 2008 Oct; 36(10):769-74. PubMed ID: 19044097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nurses in preserving patients' functional independence: Zoledronic acid--evidence and experience in metastatic bone disease.
    Fitch MI
    Eur J Oncol Nurs; 2007; 11 Suppl 2():S27. PubMed ID: 17804295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.